{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:51:52Z","timestamp":1776977512907,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12911-015-0140-z","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T16:52:50Z","timestamp":1427215970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["From prescription drug purchases to drug use periods \u2013 a second generation method (PRE2DUP)"],"prefix":"10.1186","volume":"15","author":[{"given":"Antti","family":"Tanskanen","sequence":"first","affiliation":[]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[]},{"given":"Marjaana","family":"Koponen","sequence":"additional","affiliation":[]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[]},{"given":"Riitta","family":"Ahonen","sequence":"additional","affiliation":[]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2009","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol. 2009;106:86\u201394.","journal-title":"Basic Clin Pharmacol"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/pds.3457","volume":"22","author":"B Wettermark","year":"2013","unstructured":"Wettermark B, Zo\u00ebga H, Furu K, Korhonen M, Hallas J, N\u00f8rgaard M, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research \u2013 a literature review. Pharmacoepidemiol Drug Saf. 2013;22:691\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"140_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0895-4356(01)00396-1","volume":"54","author":"AK Mantel-Teeuwisse","year":"2001","unstructured":"Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, de Boer A. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol. 2001;54:1181\u20136.","journal-title":"J Clin Epidemiol"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/pds.1549","volume":"17","author":"LN Nielsen","year":"2008","unstructured":"Nielsen LN, Loggegaard E, Andreasen AH, Keiding N. Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf. 2008;17:384\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"140_CR5","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Defined daily dose. \n                    http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/\n                    \n                   Accessed Sep 3, 2013."},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jclinepi.2005.05.005","volume":"59","author":"BL Wijk Van","year":"2006","unstructured":"Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol. 2006;59:11\u20137.","journal-title":"J Clin Epidemiol"},{"key":"140_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"S Andrade","year":"2006","unstructured":"Andrade S, Kahler K, Frech F, Chan A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"140_CR8","first-page":"449","volume":"11","author":"R Sikka","year":"2005","unstructured":"Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):449\u201357.","journal-title":"Am J Manag Care"},{"key":"140_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jclinepi.2005.12.012","volume":"59","author":"RJ Glynn","year":"2006","unstructured":"Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006;59:819\u201328.","journal-title":"J Clin Epidemiol"},{"key":"140_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00228-012-1293-7","volume":"68","author":"C \u00d8stergaard","year":"2012","unstructured":"\u00d8stergaard C, Hallas J, Bak S, de Pont Christensen R, Gaist D. Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol. 2012;68:1631\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"140_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/1756-0500-7-796","volume":"7","author":"A Tanskanen","year":"2014","unstructured":"Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, et al. From prescriptions to drug use periods \u2013 things to notice. BMC Res Notes. 2014;7:796. doi:10.1186\/1756-0500-7-796.","journal-title":"BMC Res Notes."},{"key":"140_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","volume":"27","author":"GH Gislason","year":"2006","unstructured":"Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27:1153\u20138.","journal-title":"Eur Heart J."},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","volume":"113","author":"GH Gislason","year":"2006","unstructured":"Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, et al. Risk of death or reinfarction associated with the Use of selective cyclooxygenase-2 inhibitors and nonselective Nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation. 2006;113:2906\u201313.","journal-title":"Circulation."},{"key":"140_CR14","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/archpsyc.63.12.1358","volume":"63","author":"J Tiihonen","year":"2006","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide and overall mortality in a nationwide cohort. Arch Gen Psych. 2006;63:1358\u201367.","journal-title":"Arch Gen Psych"},{"issue":"4","key":"140_CR15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-140282","volume":"41","author":"H Taipale","year":"2014","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer\u2019s disease. J Alzheimers Dis. 2014;41(4):1223\u20138. doi:10.3233\/JAD-140282.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"140_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/YIC.0000000000000032","volume":"29","author":"H Taipale","year":"2014","unstructured":"Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Anti-dementia drug use among community-dwelling individuals with Alzheimer\u2019s disease in Finland \u2013nationwide register-based study. Int Clin Psychopharmacol. 2014;29(4):216\u201323. doi:10.1097\/YIC.0000000000000032.","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"140_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/JCP.0000000000000133","volume":"34","author":"H Taipale","year":"2014","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Antipsychotic doses among community-dwelling persons with Alzheimer\u2019s disease in Finland. J Clin Psychopharmacol. 2014;34(4):435\u201340. doi:10.1097\/JCP.0000000000000133.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"140_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/JCP.0000000000000218","volume":"34","author":"S Torvinen-Kiiskinen","year":"2014","unstructured":"Torvinen-Kiiskinen S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Concomitant Use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer\u2019s disease. J Clin Psychopharmacol. 2014;34(6):722\u20137. doi:10.1097\/JCP.0000000000000218.","journal-title":"J Clin Psychopharmacol"},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/CLEP.S46622","volume":"5","author":"AM Tolppanen","year":"2013","unstructured":"Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, et al. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer\u2019s disease research \u2013 the Medication use among persons with Alzheimer\u2019s disease (MEDALZ-2005) study. Clin Epidemiol. 2013;5:277\u201385.","journal-title":"Clin Epidemiol"},{"key":"140_CR20","doi-asserted-by":"crossref","unstructured":"Krippendorff N, Krippendorff\u2019s alpha, in Salkind N (ed.), Encyclopedia of Research Desing, 2010, 669\u2013674, doi:10.4135\/9781412961288.n206","DOI":"10.4135\/9781412961288.n206"},{"issue":"9690","key":"140_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620\u20137. doi:10.1016\/S0140-6736(09)60742-X.","journal-title":"Lancet"},{"issue":"11","key":"140_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pds.3346","volume":"21","author":"M Purhonen","year":"2012","unstructured":"Purhonen M, Koponen H, Tiihonen J, Tanskanen A. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort. Pharmacoepidemiol Drug Saf. 2012;21(11):1227\u201331. doi:10.1002\/pds.3346. Epub 2012 Sep 2.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-015-0140-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-015-0140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-015-0140-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-015-0140-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:39:00Z","timestamp":1551184740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-015-0140-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1186\/s12911-015-0140-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"9 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}